Washington Marriott Encourages Guests to "Find Their Own

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Washington Marriott Encourages Guests to "Find Their Own DC"

WASHINGTON, DC--(Marketwired - Aug 5, 2013) -  With so many sights to see and diverse and exciting neighborhoods to visit, the Nation's Capital is considered one of the most unique cities in the country. The Washington Marriott is making it easy to get around the city to find the many family friendly and free things to do by offering the "Find Your Own DC" package.

The "Find Your Own DC" package includes $15 worth of DC Circulator bus cards, ( www.dccirculator.com/ ) which will allow guests to hop on the easy to navigate Circulator bus routes that will take them to various neighborhoods, like Georgetown , Dupont Circle , Embassy Row, and Capitol Hill. The "Find Your Own DC" package also includes complimentary in-room WiFi and guests are encouraged to share their best DC moments on www.facebook.com/washingtonmarriott .

In addition, Washington Marriott is an early adopter of Marriott Hotel's new mobile check-in offering smartphone users a convenient, easier and faster way to check-in. Through the use of the Marriott Mobile App, all Marriott Rewards members can check-in after 4pm the day before their arrival and receive an automatic notification when their room is ready.

Package rates start at $159. Rates are per room, per night based on availability and exclude tax and gratuities. Offer does not apply to groups of 10 or more, other terms and conditions apply. For more information or reservations, please call 888-270-9384 or visit http://www.marriott.com/hotels/travel/waswe-w...-marriott/ . Refer to promotion code: ZJL.

The Washington Marriott is situated at 1221 22 nd Street at M Street NW near the energetic Georgetown and Dupont Circle neighborhoods. Minutes away from government agencies, K Street , and Washington's central business district, the Washington Marriott hotel near Dupont Circle is an ideal hotel destination for business travelers to make it their office away from the office.

About Marriott Hotels With 500 hotels and resorts in nearly 60 countries around the world, Marriott Hotels is evolving travel through every aspect of the guest's stay, enabling the next generation to Travel Brilliantly. Boldly transforming itself for mobile and global travelers who blend work and play, Marriott leads the industry with innovations, including the Greatroom, Future of Meetings and Mobile Guest Services that elevates style & design and technology. All Marriott hotels participate in the award winning Marriott Rewards frequent travel program that allows members to earn hotel points or airline miles for every dollar spent during each stay. For more information, visit www.MarriottHotels.com . To join the ongoing Marriott conversation, like us on Facebook ( Facebook.com/Marriott ) and follow us on Twitter ( Twitter.com/Marriott , @Marriott).

CONTACT : Washington Marriott 1221 22nd Street NW Washington, DC 20037 1-202-872-1500 http://www.marriott.com/hotels/travel/waswe-w...-marriott/

Scroll down for more posts ▼

Top 10 Most Recent News Articles

DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 8

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 371

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 283

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 334

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 442

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 247

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 278

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 460

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 522

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 438

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading

Top 5 Most Recently Viewed Articles

HCW Biologics Advances T-Cell Engagers for Solid Tumors

Updated Category News Views 181

HCW Biologics Unveils Innovative Treatments for Solid Tumors HCW Biologics Inc., a clinical-stage biopharmaceutical company, recently announced important developments in its research on second-generation, multi-specific T-cell engagers. These therapies specifically target solid tumors, notably pancreatic cancer, utilizing the company's proprietary TRBC product discovery...

Continue Reading
Highlights of the Upcoming Small Cap Growth Investor Event

Updated Category News Views 56

Overview of the Small Cap Growth Virtual Investor Conference The Small Cap Growth Virtual Investor Conference is set to take place soon, bringing together a diverse group of companies and investors. This exciting virtual event will provide a platform for companies to showcase their offerings to interested investors from various backgrounds. The conference promises an...

Continue Reading
Crexi Auction Performance Highlights Investor Reengagement

Updated Category News Views 286

Introduction to Crexi Auction's 2025 Performance As the landscape of commercial real estate evolves, Crexi Auction stands out with remarkable performance metrics indicating a strong rebound in market confidence. Recent reports highlight a 96% close rate for Crexi Auction during the first half of the year, showcasing a notable 10% year-over-year increase in transaction...

Continue Reading
Digihost and NANO Nuclear Jointly Propel New York's Energy Future

Updated Category News Views 145

Digihost and NANO Nuclear Join Forces for Renewable Energy Digihost Technology Inc. and NANO Nuclear Energy Inc. have united to submit a proposal to the New York State Energy Research and Development Authority (NYSERDA). Their aim? To facilitate the development of cutting-edge, clean energy solutions that will revolutionize New York's energy landscape. This collaboration...

Continue Reading
Syndax Pharmaceuticals (NASDAQ: SNDX) Faces Market Challenges

Updated Category News Views 151

Syndax Pharmaceuticals (NASDAQ: SNDX) and Its Market Journey Syndax Pharmaceuticals Inc. (NASDAQ: SNDX) has recently made headlines as its stock price has fallen to a 52-week low of $12.75. This decline is indicative of the current hurdles the biopharmaceutical company is facing in a challenging market landscape. Investors have noted that the stock is currently in an...

Continue Reading